[Immune therapy against tumors based on the ubiquitin-proteasome pathway].
Himeno
Kunisuke
K
Department of Parasitology, Graduate School of Medical Sciences, Kyushu University.
Hisaeda
Hajime
H
D000818:Animals; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000235:genetics; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D050939:Gene Fusion; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D018832:Molecular Chaperones; D009369:Neoplasms / Q000235:genetics* / Q000276:immunology / Q000628:therapy*; D046988:Proteasome Endopeptidase Complex / Q000502:physiology*; D025801:Ubiquitin / Q000235:genetics / Q000378:metabolism*; D019444:Vaccines, DNA
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D018832:Molecular Chaperones; D025801:Ubiquitin; D019444:Vaccines, DNA; D046988:Proteasome Endopeptidase Complex